| Product Name | MF | CAS | Details |
|---|
| N-(2-Phenylethyl)-1,3-thiazol-2-amine | C11H12N2S | 91088-91-4 | Details |
| Tetraethylene glycol monooctyl ether | C16H34O5 | 19327-39-0 | Details |
| Methyl 3,4-diaminobutanoate dihydrochloride | C5H14Cl2N2O2 | 1554121-30-0 | Details |
| H-NKGENAQAI-OH | Details |
| Histrelin Acetate | C66H86N18O12 | 76712-82-8 | Details |
| N-[6-(4-Bromophenoxy)pyridin-3-yl]-2-chloroacetamide | C13H10BrClN2O2 | 1235438-88-6 | Details |
| Tricyclo[7.2.1.0,2,7]dodeca-2,4,6-trien-8-one | C12H12O | 5387-19-9 | Details |
| N-(2-(3,4-dimethoxyphenyl)ethyl)(4-chlorophenyl)formamide | C17H18ClNO3 | 98841-62-4 | Details |
| Mouse IgG1 (FITC) | Details |
| Ethyl 2-oxo-3,4-dihydro-1H-quinoline-3-carboxylate | C12H13NO3 | 26906-40-1 | Details |
| Heparin derived dp26 saccharide ammonium salt | Details |
| 4-Chloro-N-ethyl-2-fluoroaniline | C8H9ClFN | 1152960-41-2 | Details |
| 5-Amino-2-methyl-1,2-dihydroisoquinolin-1-one | C10H10N2O | 42792-97-2 | Details |
| 5-Amino-2-ethoxybenzene-1-sulfonamide | C8H12N2O3S | 1050886-42-4 | Details |
| Dengue NS1 protein (Serotype 4) | Details |
| Chicken anti-Rabbit IgG h+l (min. reactivity w/ Hu, Ms) - Affinity Purified | Details |
| 17-Trifluoromethylphenyl trinor prostaglandin f2α methyl ester | C25H33F3O5 | 195503-20-9 | Details |
| 1-(Azepan-1-yl)-2-[(propan-2-yl)amino]ethan-1-one | C11H22N2O | 1019121-12-0 | Details |
| R3HDM2 Blocking Peptide | Details |
| Dibenzo-11-chloro[b,f][1,4]thiazepine | C13H8ClNS | 13745-86-3 | Details |
| 4-(4-Chlorophenyl)-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol | C13H9ClN4S | 74270-76-1 | Details |
| 2-Bromofuran-3-carbaldehyde | C5H3BrO2 | 223557-24-2 | Details |
| N,N,N',N'-Ethylenediaminetetrakis | C6H20N2O12P4 | 1429-50-1 | Details |
| 4-Bromo-1,2-bis(trifluoromethyl)benzene | C8H3BrF6 | 320-29-6 | Details |
| 3-Hydroxy-11-ursen-28,13-olide | C30H46O3 | 35959-05-8 | Details |
| 4-(bis(3-(tert-butyl)-1-methyl-5-oxo-2-pyrazolin-4-yl)methyl)benzenecarbonitrile | C24H31N5O2 | 1022584-84-4 | Details |
| 2-Amino-5-(tert-butylamino)-4-fluorobenzoic acid | C11H15FN2O2 | 1248655-94-8 | Details |
| THAP11 protein (His tag) | Details |
| 2-(2-Ethylphenyl)acetic acid | C10H12O2 | 19418-95-2 | Details |
| H-L^NILNNK^-OH | Details |
| 3-Bromo-2-methoxybenzyl alcohol | C8H9BrO2 | 205873-57-0 | Details |
| 2-Bromo-6-methylbenzene-1-sulfonamide | C7H8BrNO2S | 1261758-21-7 | Details |
| VPS26B antibody | Details |
| L-Cysteinesulfinic acid, monohydrate | HO2SCH2CH(NH2)CO2HH2O | 207121-48-0 | Details |
| 4'-Demethyleucomin | C16H12O5 | 34818-83-2 | Details |
| 5-Deoxy-5-fluoro-D-galactose | Details |
| SUB1 protein (His tag) | Details |
| N-[2-(3,4-dimethoxyphenyl)ethyl]-1-phenylcyclopentane-1-carboxamide | C22H27NO3 | 151156-92-2 | Details |
| H-RPTLR-OH | Details |
| rac-Methyl({[(2R,3R)-3-(3-methyl-1H-1,2,4-triazol-5-yl)oxolan-2-yl]methyl})amine dihydrochloride | 2155840-09-6 | Details |
| (1S,4S)-tert-Butyl 2,5-diazabicyclo[2.2.1]heptane-2-carboxylate | C10H18N2O2 | 198989-07-0 | Details |
| 4-Methoxyphenyl 2,3,6-tri-O-acetyl-4-O-[2,4,6-tri-O-acetyl-3-O-(3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-b-D-glucopyranosyl)-b-D-gal actopyranosyl]-b-D-glucopyranoside | C51H59NO27 | Details |
| 1-Methoxy-3-methyl-9H-carbazole | C14H13NO | 4532-33-6 | Details |
| 3'-Deoxycytidine | C9H13N3O4 | 7057-33-2 | Details |
| 4-Iodo-1H-pyrazolo[3,4-b]pyridine | C6H4IN3 | 861881-02-9 | Details |
| Salmonella Typhi IgA Positive Human Plasma | Details |
| Ferulic acid acyl-b-D-glucoside | C16H20O9 | 7196-71-6 | Details |
| 3-(Aminomethyl)-4-fluorobenzonitrile | C8H7FN2 | 1016798-28-9 | Details |
| 4-(Piperidin-1-yl)benzene-1-carboximidamide dihydrochloride | C12H19Cl2N3 | 1354953-87-9 | Details |
| (S)-Carprofen | C15H12ClNO2 | 52263-84-0 | Details |
| Methyl-(3-phenyl-[1,2,4]oxadiazol-5-ylmethyl)-amine hydrochloride | C10H12ClN3O | 1185300-67-7 | Details |
| 6Beta-Hydroxyipolamiide | C17H26O12 | 87797-84-0 | Details |
| SERTAD1 protein (His tag) | Details |
| N4-Benzoylcytidine | C16H17N3O6 | 13089-48-0 | Details |
| N-Phenyloxolan-3-amine | C10H13NO | 162851-41-4 | Details |
| 3-(Ferrocenyl)-acrylic acid | C13H12FeO2 | 12154-65-3 | Details |
| 2-Amino-4-hydroxypyridine | C5H6N2O | 33631-05-9 | Details |
| 5-Chloropyrazine-2,3-dicarbonitrile | 72111-57-0 | Details |
| Ethyl 2-(3-bromo-1H-pyrazol-1-yl)acetate | C7H9BrN2O2 | 1427022-51-2 | Details |
| CCNB3 antibody | Details |
| 4-(2-Aminophenyl)pyrrolidin-2-one | C10H12N2O | 1498949-07-7 | Details |
| 5-Amino-1-(2-naphthyl)-1H-pyrazole-4-carboxamide | C14H12N4O | 307343-86-8 | Details |
| 5-(Aminomethyl)-1,3,4-thiadiazol-2-amine dihydrochloride | C3H7ClN4S | 1211483-84-9 | Details |
| 2-(2,4-Difluorophenyl)propanedinitrile | C9H4F2N2 | 1803582-90-2 | Details |
| (5-Oxo-2,3,6,7,8,9-hexahydro-5H-[1,3]thiazolo[2,3-b]quinazolin-3-yl)acetic acid | C12H14N2O3S | 1105190-90-6 | Details |
| 1-(4-((6,7-dimethoxy(3,4-dihydroisoquinolyl))methyl)phenyl)-3-(fluoren-2-yl)urea | C32H29N3O3 | 1022510-56-0 | Details |
| Complement C5Light | Details |
| NF45 antibody | Details |
| CD36 antibody | Details |
| 1-(3-Fluoro-5-hydroxyphenyl)ethanone | C8H7FO2 | 1214333-95-5 | Details |
| 4,7-Dichloropyrido[3,2-d]pyrimidine | C7H3Cl2N3 | 917757-12-1 | Details |
| 2-Chlorotrityl chloride resin | C19H14Cl2 | 42074-68-0 | Details |
| HSD11B2 Blocking Peptide | Details |
| 8a-(Chloromethyl)-octahydroindolizine hydrochloride | 2241130-91-4 | Details |
| 2-Chloro-3,4-dihydroxybenzoic acid | C7H5ClO4 | 87932-50-1 | Details |
| 2-Chloro-1-{4-ethyl-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}ethan-1-one | C11H14ClNOS | 1182908-09-3 | Details |
| PSG9 antibody | Details |
| 4-(2,2-Dimethylpropyl)pyrrolidin-2-one | C9H17NO | 1497268-53-7 | Details |
| Methyl 2-(pyrrolidin-3-yl)-1,3-thiazole-5-carboxylate hydrochloride | 2137717-09-8 | Details |
| 3-(3-Methylbutyl)-4-oxo-3,4-dihydrophthalazine-1-carboxylic acid | C14H16N2O3 | 565174-87-0 | Details |
| 1-(2-Bromophenyl)-1H-pyrazole-4-carboxylic acid | C10H7BrN2O2 | 1153041-33-8 | Details |
| N-(Furan-2-ylmethyl)-2-hydroxy-N-methylacetamide | C8H11NO3 | 926235-09-8 | Details |
| Collagen Type I alpha 2 Blocking Peptide | Details |
| Lithium 2-(1,3,4-thiadiazol-2-yl)acetate | C4H5LiN2O2S | 2243513-35-9 | Details |
| 8-Methoxycirsilineol | C19H18O8 | 16520-78-8 | Details |
| 2-{[(Benzyloxy)carbonyl]amino}-5-hydroxybenzoic acid | C15H13NO5 | 214957-88-7 | Details |
| 5-Amino-4-methylpyridine-2-carboxylic acid hydrochloride | C7H9ClN2O2 | 2248334-35-0 | Details |
| Ethyl 3-(3-methylpyridin-2-yl)-3-oxopropanoate | C11H13NO3 | 1248195-40-5 | Details |
| 2-Chloro-N-[4-(2-chloroacetamido)-3-nitrophenyl]acetamide | C10H9Cl2N3O4 | 556016-58-1 | Details |
| 4-Methoxy-2-methyl-2-butanethiol | C6H14OS | 94087-83-9 | Details |
| Tetrahydro-?N-?(4-?methoxyphenyl)?-3-?thiophenamine 1,?1-?dioxide | C11H15NO3S | 303992-20-3 | Details |
| 4-(Dimethylamino)-3-fluorobenzoic acid | C9H10FNO2 | 160658-70-8 | Details |
| H-AGGKAGKDSGKAKTKAVSR-OH | Details |
| 4-(2-Chlorophenoxy)butanoic acid | C10H11ClO3 | 5057-52-3 | Details |
| Telomestatin | C26H14N8O7S | 265114-54-3 | Details |
| H-AQDFVQWLMNT-OH | Details |
| DACT3 antibody | Details |
| N-(Pyridin-4-ylmethyl)methanesulfonamide hydrochloride | C7H11ClN2O2S | 1197826-26-8 | Details |
| 5-{[(9H-Fluoren-9-ylmethoxy)carbonyl]amino}-1-benzofuran-2-carboxylic acid | C24H17NO5 | 1675984-44-7 | Details |
| 2-((6,8-dichloro-4-oxo-4H-chromen-3-yl)methylene)indane-1,3-dione | C19H8Cl2O4 | 1024223-96-8 | Details |
| Product Total： Product Page： | ||||
| 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 | ||||